Back

Bone morphogenetic protein 10 as predictor for adverse outcomes in patients with atrial fibrillation

27 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Epidemiological aspects of atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Elisa Hennings

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.
Professor L. Fauchier (Tours, FR)
Abstract Slides
Presentation thumbnail
Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND
Mr A. Al Mubarak (Groningen, NL)
Abstract Slides
Presentation thumbnail
Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry
Doctor G. Romiti (Rome, IT)
Abstract Slides
Presentation thumbnail
Prediction of incident atrial fibrillation with GDF-15 and echocardiographic left atrial volumes: data from the Akershus cardiac examination 1950 study
Doctor P. Roenningen (Baerum, NO)
Abstract Slides
Presentation thumbnail
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Doctor W. Ding (Liverpool, GB)
Abstract Slides

Access the full session

Session thumbnail
Epidemiological aspects of atrial fibrillation

The Event

Event poster

ESC Congress 2022

27 August 2022 12:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources